Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
J Solomon, MC Festa, YS Chatzizisis… - Pharmacology & …, 2023 - Elsevier
Diabetes drives an increasing burden of cardiovascular and renal disease worldwide,
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …
Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
J Solomon, MC Festa, YS Chatzizisis… - Pharmacology & …, 2023 - pubmed.ncbi.nlm.nih.gov
Diabetes drives an increasing burden of cardiovascular and renal disease worldwide,
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …
Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
J Solomon, MC Festa, YS Chatzizisis… - Pharmacology and …, 2023 - experts.nebraska.edu
Diabetes drives an increasing burden of cardiovascular and renal disease worldwide,
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …
Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease.
J Solomon, MC Festa, YS Chatzizisis… - Pharmacology & …, 2022 - europepmc.org
Diabetes drives an increasing burden of cardiovascular and renal disease worldwide,
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …
motivating the search for new hypoglycemic agents that confer cardiac and renal protective …